DK274990A - Vaevsplasminogenaktivator-(t-pa)-varianter, dma-sekvenser, som koder for disse, replicerbare udtrykkelsesvektorer for dna-sekvenserne, eukaryote vaertsceller transformeret med vektorerne og farmaceutiske praeparater indeholdende t-pa-varianterne - Google Patents

Vaevsplasminogenaktivator-(t-pa)-varianter, dma-sekvenser, som koder for disse, replicerbare udtrykkelsesvektorer for dna-sekvenserne, eukaryote vaertsceller transformeret med vektorerne og farmaceutiske praeparater indeholdende t-pa-varianterne Download PDF

Info

Publication number
DK274990A
DK274990A DK274990A DK274990A DK274990A DK 274990 A DK274990 A DK 274990A DK 274990 A DK274990 A DK 274990A DK 274990 A DK274990 A DK 274990A DK 274990 A DK274990 A DK 274990A
Authority
DK
Denmark
Prior art keywords
vectors
variants
dna sequences
cells transformed
eukariote
Prior art date
Application number
DK274990A
Other languages
English (en)
Other versions
DK175938B1 (da
DK274990D0 (da
Inventor
Stephen Anderson
Bruce Keyt
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK274990D0 publication Critical patent/DK274990D0/da
Publication of DK274990A publication Critical patent/DK274990A/da
Application granted granted Critical
Publication of DK175938B1 publication Critical patent/DK175938B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK199002749A 1988-05-20 1990-11-19 Plasminogenaktivator-varianter, DNA-sekvenser, vektorer, celler og cellekulturer, der omfatter DNA-sekvenser, der koder for sådanne varianter, samt sammensætninger til behandling af karsygdom eller -tilstand, der omfatter en sådan variant DK175938B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19690988A 1988-05-20 1988-05-20
US19690988 1988-05-20
PCT/US1989/001947 WO1989011531A1 (en) 1988-05-20 1989-05-04 Variants of plasminogen activators and processes for their production
US8901947 1989-05-04

Publications (3)

Publication Number Publication Date
DK274990D0 DK274990D0 (da) 1990-11-19
DK274990A true DK274990A (da) 1991-01-18
DK175938B1 DK175938B1 (da) 2005-07-25

Family

ID=22727245

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199002749A DK175938B1 (da) 1988-05-20 1990-11-19 Plasminogenaktivator-varianter, DNA-sekvenser, vektorer, celler og cellekulturer, der omfatter DNA-sekvenser, der koder for sådanne varianter, samt sammensætninger til behandling af karsygdom eller -tilstand, der omfatter en sådan variant

Country Status (12)

Country Link
EP (1) EP0424405B1 (da)
JP (1) JP2928798B2 (da)
AT (1) ATE111525T1 (da)
AU (1) AU624158B2 (da)
CA (1) CA1341432C (da)
DE (1) DE68918279T2 (da)
DK (1) DK175938B1 (da)
ES (1) ES2013500A6 (da)
HK (1) HK1007333A1 (da)
IL (1) IL90146A (da)
NZ (1) NZ229081A (da)
WO (1) WO1989011531A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098840A (en) * 1986-07-03 1992-03-24 The Green Cross Corporation Human prourokinase mutants
US5218092A (en) * 1988-09-29 1993-06-08 Kyowa Hakko Kogyo Co., Ltd. Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains
HUT52559A (en) * 1988-12-12 1990-07-28 Yamanouchi Pharma Co Ltd Process for production of proteins with trombolitic effect
JPH0387180A (ja) * 1989-05-18 1991-04-11 Green Cross Corp:The 変異ヒトプロウロキナーゼ、その製法、ｄｎａ配列、プラスミド、宿主
US5246850A (en) * 1990-07-31 1993-09-21 Genentech, Inc. DNA molecules encoding human tissue plasminogen activator variants with decreased clearance, vectors, and host cells
WO1992002612A2 (en) * 1990-07-31 1992-02-20 Genentech, Inc. Tissue plasminogen activator variants with decreased clearance
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
US5595736A (en) * 1991-04-22 1997-01-21 Eli Lilly And Company Compounds and methods for treatment of thromboembolic disorders
US5223408A (en) * 1991-07-11 1993-06-29 Genentech, Inc. Method for making variant secreted proteins with altered properties
AU664469B2 (en) * 1992-06-03 1995-11-16 Genentech Inc. Tissue plasminogen activator glycosylation variants with improved therapeutic properties
US5945432A (en) * 1995-12-22 1999-08-31 The University Of Vermont And State Agricultural College Thrombolytic agents and thienopyridine derivatives in acute stroke
US7553930B2 (en) 2003-01-06 2009-06-30 Xencor, Inc. BAFF variants and methods thereof
NZ548513A (en) * 2004-01-14 2010-05-28 Univ Ohio Methods of producing peptides/proteins in plants and peptides/proteins produced thereby

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8528321D0 (en) * 1985-11-18 1985-12-24 Ciba Geigy Ag Modified fibrinolytic agents
AU605124B2 (en) * 1985-12-23 1991-01-10 Behringwerke Aktiengesellschaft Novel peptide plasminogen activators
DK43387A (da) * 1986-01-29 1987-07-30 Beecham Group Plc Fibrinolytisk enzym
AU7090787A (en) * 1986-02-19 1987-10-08 Beecham Group Plc Tissue plasminogen activator
IE81073B1 (en) * 1986-03-18 2000-01-12 Genentech Inc Modified human tissue-type plasminogen activator and its preparation

Also Published As

Publication number Publication date
IL90146A (en) 1994-10-07
EP0424405B1 (en) 1994-09-14
ATE111525T1 (de) 1994-09-15
DE68918279T2 (de) 1995-03-23
JPH03504327A (ja) 1991-09-26
EP0424405A1 (en) 1991-05-02
HK1007333A1 (en) 1999-04-09
AU3744889A (en) 1989-12-12
DE68918279D1 (de) 1994-10-20
DK175938B1 (da) 2005-07-25
AU624158B2 (en) 1992-06-04
CA1341432C (en) 2003-06-17
ES2013500A6 (es) 1990-05-01
DK274990D0 (da) 1990-11-19
NZ229081A (en) 1991-03-26
WO1989011531A1 (en) 1989-11-30
IL90146A0 (en) 1989-12-15
JP2928798B2 (ja) 1999-08-03

Similar Documents

Publication Publication Date Title
DK274990A (da) Vaevsplasminogenaktivator-(t-pa)-varianter, dma-sekvenser, som koder for disse, replicerbare udtrykkelsesvektorer for dna-sekvenserne, eukaryote vaertsceller transformeret med vektorerne og farmaceutiske praeparater indeholdende t-pa-varianterne
ZA90861B (en) Derivative of tissue-type plasminogen activator
DK36991A (da) Vaevsplasminoaktivator-(t-pa)-variant med zymogene eller fibrinspecifikke eller plasmakoagel-specifikke egenskaber, fremgangsmaade til fremstilling deraf, dna-sekvens, som koder for varianten, replicerbar udtrykkelsesvektor for denne og vaertsceller transformeret med vektoren
DK215287D0 (da) Dna-sekvenser, der koder for et protein med angiogen virkning, vektorer, vaertsceller og fremgangsmaader til udtrykkelse af proteinet, samt laegemidler indeholdende dette
SE8701921L (sv) Ny farmaceutisk anvendning
FI882605A0 (fi) Menetelmä, jonka avulla voidaan valmistaa suuren spesifisen tilavuusaktiivisuuden omaavaa liuosta proteiinista, jolla on kudosplasminogeeniaktivaattori(t-PA)-aktiivisuutta
KR900701832A (ko) 항-트롬빈
KR890000521A (ko) 변형된 성장 인자 도메인을 갖는 조직 플라즈미노겐 활성제 동족체
DK0517756T3 (da) Vævs-plasminogenaktivator med fibrinspecifikke egenskaber
ES2067326T3 (es) Variante especifica de activador de plasminogeno tisular.
EP0326013A3 (en) Novel proteins derived from human alpha2-plasmin inhibitor or proteins similar thereto
EP0386240A4 (en) Novel polypeptide compounds
KR870008588A (ko) 신규 인체 조직형 플라스미노겐 활성제 폴리펩티드

Legal Events

Date Code Title Description
PUP Patent expired